Brief: Mdxhealth Reports Q1-2026 Results
13/05/2026 21:38
May 13 (Reuters) - MDxHealth SA MDXH.O: MDXHEALTH REPORTS Q1-2026 RESULTS TO DISCONTINUE RESOLVE UTI OFFERING AND PLANO, TEXAS LAB OPERATIONS SETS 2026 CORE CANCER BUSINESS REVENUE GUIDANCE AT $110-$115 MILLION EXCLUDING RESOLVE Q1 2026 REVENUE $27.4 MILLION, UP 13% YEAR-OVER-YEAR MDXHEALTH: CONTESTING $10.4 MILLION MEDICARE CONTRACTOR'S RECOUPMENT DECISION FROM NOVITAS ON RETROSPECTIVE REVIEW OF SOME HISTORICAL RESOLVE MDX CLAIMS : QTRLY LOSS PER SHARE 17 CENTS Q1 EARNINGS PER SHARE VIEW $-0.15, REVENUE VIEW $30.6 MILLION -- LSEG IBES DATA Source text: ID:nGNX6QXlVS Further company coverage: MDXH.O ((Reuters.Briefs@thomsonreuters.com;))